Clinical trial
Combination Chemotherapy With or Without Prednisone in Treating Patients With…
NCT00003584 · University of New Mexico, Other · Completed
Key facts
| NCT number | NCT00003584 |
|---|---|
| Title | Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer |
| Official title | A Phase II Trial of Combination Vinorelbine-Estramustine With or Without Prednisone for High Risk and Recurrent, Advanced and Metastatic Renal Cell Carcinoma |
| Lead sponsor | University of New Mexico, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug |
| Interventions | estramustine phosphate sodium, prednisone, vinorelbine tartrate |
| Enrollment | 35 |
| Start date | Jul 1, 1998 |
| Primary completion | Dec 1, 2000 |
| Completion | Dec 1, 2000 |
| First posted | Jun 9, 2004 |
| Last update posted | May 12, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: